[Skip to Content]
[Skip to Content Landing]
September 28, 1957

BCG Vaccination Against Tuberculosis

JAMA. 1957;165(4):420. doi:10.1001/jama.1957.02980220104027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


BCG vaccination against tuberculosis is accepted, with few exceptions, in virtually every country in the world, and it is estimated that over 100 million people have been so vaccinated. In the United States, BCG vaccine is widely used but on a small scale. The American Trudeau Society, Public Health Service, and the Council on Drugs of the American Medical Association recommend its use for persons unavoidably exposed to tuberculosis and for groups considered to have inferior resistance and who live in communities with unusually high mortality from this cause. Despite these recommendations, most persons in the recommended groups have not been vaccinated.

This volume is directed toward the medical profession and allied groups with the hope of clarifying the problem. It does not attempt to review all the vast literature. The subjects considered are immunity in tuberculosis; vaccines other than BCG against tuberculosis; history of BCG; cultural characteristics, morphology, and

First Page Preview View Large
First page PDF preview
First page PDF preview